Layout:
Home > (PACB, IPCI, GBLHF, THER) Stock under Consideration by DoubleInStocks.com

(PACB, IPCI, GBLHF, THER) Stock under Consideration by DoubleInStocks.com

October 10th, 2011 at 12:15 pm





Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of Single Molecule Real Time (SMRT®) sequencing products, announced the appointment of Michael J. Glynn as Chief Commercial Officer. Michael Glynn has more than 40 years of experience in global commercial operations. Prior to joining Pacific Biosciences, Mr. Glynn served as Regional President, Japan - Asia Pacific and Senior Vice President at Genzyme Corporation. In this role, he was responsible for leading and managing Genzyme's businesses in Japan and Asia Pacific from the company's regional headquarters in Singapore.

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and proteins.

Read full article and disclaimer at : http://doubleinstocks.com/?p=18988

0 Responses to “(PACB, IPCI, GBLHF, THER) Stock under Consideration by DoubleInStocks.com”

Leave a Reply

(Note: If you were logged in, we could automatically fill in these fields for you.)
*
Will not be published.
   

* Please spell out the number 4.  [ Why? ]

vB Code: You can use these tags: [b] [i] [u] [url] [email]